Spruce Biosciences Operating Income

Spruce Biosciences (SPRB) currently reports a operating income of $-34M as of March 2026. That compares with $-58M in the prior-year period — up 41.4% year over year. Use the charts on this page to explore Spruce Biosciences's operating income history and peer comparisons.

Spruce Biosciences's operating income increased from $-58M to $-34M — a 41.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Spruce Biosciences reported $-34M in operating income as of March 2026. That compares with $-58M in the prior-year period — up 41.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-34M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Spruce Biosciences, and consider following SPRB for alerts when major investors trade the stock.

Spruce Biosciences is classified in the Healthcare sector. On operating income, it currently shows $-34M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPRB with unrelated industries.